Chapman Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$69.1K Hold
800
– – 0.05% 169
2026
Q2
$72.4K Hold
800
– – 0.05% 170
2026
Q1
$64.1K Hold
800
– – 0.05% 172
2025
Q4
$68.2K Hold
800
– – 0.05% 168
2025
Q3
$62.2K Hold
800
– – 0.04% 175
2025
Q2
$62.6K Buy
+800
New +$59.7K 0.05% 134
2024
Q4
$81.4K Buy
+1,100
New +$77K 0.07% 134

Other funds holding EW

Chapman Financial Group's EW Position: Q3 2026 in Review

Chapman Financial Group held its Edwards Lifesciences (EW) position steady in Q3 2026 at 800 shares worth $69.1K. The position accounts for 0.05% of the portfolio, ranked #169.

Chapman Financial Group first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $81.4K in Q4 2024. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Chapman Financial Group held 800 shares of Edwards Lifesciences worth $69.1K as of Q3 2026.
  • Chapman Financial Group left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up 0.05% of Chapman Financial Group's portfolio in Q3 2026, its #169 holding.
  • Chapman Financial Group first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • Chapman Financial Group's Edwards Lifesciences position peaked at $81.4K in Q4 2024.
  • 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Chapman Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.